Inspire Medical Systems I... (INSP)
NYSE: INSP
· Real-Time Price · USD
86.41
0.09 (0.10%)
At close: Sep 05, 2025, 3:59 PM
86.46
0.05%
After-hours: Sep 05, 2025, 06:50 PM EDT
Inspire Medical Systems Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|
| Operating Segment Revenue | 217.09M | 201.32M |
| Operating Segment Revenue Growth | +7.83% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 9.94M | 7.71M | 8.09M | 7.36M | 8.08M | 8.24M | 189.43M | 5.79M | 6.34M | 3.41M | 134.25M | 2.91M | 3.51M | 2.96M | 75.56M | 58.3M | 49.35M | 37.77M | 42.73M | 33.12M | 10.98M | 19.27M | 18.65M | 15.75M | 14.36M | 14.8M | 11.31M |
| Non-Us Revenue Growth | +28.85% | -4.63% | +9.81% | -8.84% | -1.97% | -95.65% | +3172.81% | -8.75% | +85.90% | -97.46% | +4515.06% | -17.12% | +18.74% | -96.09% | +29.60% | +18.12% | +30.67% | -11.61% | +29.01% | +201.54% | -43.01% | +3.37% | +18.36% | +9.75% | -2.99% | +30.87% | n/a |
| United States Revenue | 207.15M | 193.61M | 231.63M | 195.83M | 187.81M | 155.77M | n/a | 147.51M | 144.75M | 124.48M | n/a | 106.28M | 87.88M | 66.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +7.00% | -16.42% | +18.28% | +4.27% | +20.57% | n/a | n/a | +1.91% | +16.28% | n/a | n/a | +20.94% | +32.29% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 159.52M | 144.29M | 141.51M | 130.39M | 132.08M | 125.62M | 124.11M | 113.25M | 112.62M | 101.99M | 94.83M | 85.6M | 76.69M | 63.56M | 58.77M | 53.24M | 48.7M | 41.91M | 38.63M | 33.22M | 26.98M | 29.05M | 28.19M | 22.43M | 20.27M | 19.57M | 16.11M | 13.46M | 12.74M | 11.21M | 10.24M | 8.18M | 7.31M | 6.63M |
| Selling, General, and Administrative Revenue Growth | +10.56% | +1.96% | +8.53% | -1.28% | +5.14% | +1.22% | +9.59% | +0.56% | +10.42% | +7.54% | +10.78% | +11.63% | +20.64% | +8.16% | +10.38% | +9.34% | +16.21% | +8.49% | +16.28% | +23.11% | -7.13% | +3.05% | +25.67% | +10.69% | +3.57% | +21.47% | +19.65% | +5.71% | +13.60% | +9.50% | +25.20% | +11.93% | +10.18% | n/a |
| Research and Development Revenue | 26.21M | 27.8M | 30.34M | 26.08M | 28.86M | 28.85M | 31.05M | 29.14M | 30.82M | 25.52M | 21.25M | 20.99M | 14.53M | 11.87M | 10.29M | 9.61M | 9.29M | 8.15M | 7.29M | 7.31M | 6.06M | 5.44M | 3.77M | 3.62M | 2.85M | 2.6M | 2.15M | 1.77M | 1.74M | 1.73M | 1.68M | 1.18M | 1.74M | 1.59M |
| Research and Development Revenue Growth | -5.73% | -8.35% | +16.31% | -9.62% | +0.03% | -7.09% | +6.55% | -5.44% | +20.78% | +20.10% | +1.21% | +44.44% | +22.44% | +15.31% | +7.07% | +3.51% | +13.91% | +11.93% | -0.30% | +20.54% | +11.47% | +44.36% | +3.97% | +27.30% | +9.34% | +20.96% | +21.51% | +2.07% | +0.29% | +2.85% | +43.03% | -32.53% | +9.42% | n/a |